Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Observational × Chemotherapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 553 Neoplasms 458 Lung Neoplasms 291 Colorectal Neoplasms 285 Carcinoma, Non-Small-Cell Lung 208 Stomach Neoplasms 204 Carcinoma, Hepatocellular 201 Prostatic Neoplasms 182 Pancreatic Neoplasms 148 Ovarian Neoplasms 137 Uterine Cervical Neoplasms 124 Colonic Neoplasms 120 Rectal Neoplasms 109 Urinary Bladder Neoplasms 94 Neoplasm Metastasis 94 Esophageal Neoplasms 83 Endometrial Neoplasms 82 Head and Neck Neoplasms 80 Precursor Cell Lymphoblastic Leukemia-Lymphoma 77 Leukemia, Myeloid, Acute 77 Recurrence 69 Brain Neoplasms 67 Melanoma 65 Disease 64 Multiple Myeloma 59 Lymphoma 57 Liver Neoplasms 57 Glioma 56 Polycystic Ovary Syndrome 53 Squamous Cell Carcinoma of Head and Neck 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03701607 2018-10-10

Effect of Chemotherapy on PD-L1 in NSCLC

Shanghai Changzheng Hospital

Chemotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡